Travere Therapeutics
TVTX
#3177
Rank
$4.82 B
Marketcap
$50.24
Share price
-1.68%
Change (1 day)
39.56%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2026 (TTM): -$1.29

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.29. In 2025 the company made an earnings per share (EPS) of -$0.29 an increase over its 2024 EPS that were of -$4.10.

EPS history for Travere Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$1.29344.83%
2025-$0.29-92.93%
2024-$4.10154.66%
2023-$1.61-63.16%
2022-$4.3744.22%
2021-$3.03-10.09%
2020-$3.37
2018-$2.5464.94%
2017-$1.54
2015$3.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-$0.19-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$0.95-26.36%๐Ÿ‡บ๐Ÿ‡ธ USA